While some believe that Hepatitis C virus (abbreviated HCV) is not particularly common, there is evidence to suggest that Hepatitis C deaths have quadrupled since 1996 and are rising faster than any other disease in the UK.
Hepatitis C virus causes an infectious disease mainly in the liver. Which eventually causes health problems in the liver or even liver cancer [1,2].
Ok, so now you’re probably asking yourselves “ how can I become infected with Hepatitis C virus??” It turns out that transmission is mainly by blood to blood contact. So if you’re a health care worker, or planing on getting a new tattoo or piercing, you should be extra careful [3,4].
And not only that, if you by any chance share personal care items with your close buddies such as razors, toothbrushes, and manicuring or pedicuring equipment, keep in mind that those items may be contaminated with blood- so you should avoid sharing them.
Mother to newborn child transmission is uncommon and may happen during pregnancy or child delivery .
Interestingly, it is unclear whether HCV is transmitted through sexual activity, so you should always use a condom ! And, last but not least, Hepatitis C is mainly prevalent among people who inject drugs, and is widespread in low- and middle-income countries (LMICs).
There is no doubt that viruses are a part of nature, yet, we continue to search for new treatments in order to prevent the spread of viral diseases that cause poorer quality of life and premature death.
The hepatitis C coalition is a group of clinicians, patient organizations and other parties who commit to the reduction of virus infection and death rate resulting from Hepatitis C, and eventually eliminating the virus.
Not until recently, they argued that too many people in the UK are chronically infected, and that improvements are needed in terms of service and help for those patients.
Coalition chair Mark Thursz said that we are fortunate to have cost effective treatments that will cure most of the HCV patients, but that we need to find those patients and treat them so that they do not die prematurely when a cure is available.
Let me tell you an interesting fact about the “cost effective treatments” Mark Thursz mentions: a course of those “cost effective treatments”  for instance Sovaldi (sofosbuvir), may cost up to $84,000!!! He can’t be serious!
Since the health budget is limited, where will the British government get the money for subsidizing theses medications???
Apparently, the 18 organizations who make up the Hepatitis C Coalition, get funding from Gilead Sciences, makers of the blockbuster Sovaldi (sofosbuvir), I mentioned above. Don’t you think that’s a bit of a conflict of interests? Well, I sure do!
But wait, why are everyone focusing on theses expensive treatments, when there is a much much cheaper and safer solution that really works???
Here’s a thought: how about using Novirin and Gene-Eden-VIR?
They are the only natural remedies on the market which have been clinically proven to be very much effective!
These products are designed to help the immune system target the virus in its latent state . Furthermore, whats even more striking is that they are reasonably affordable.
[Both products can be ordered online on the Novirin and Gene-Eden-VIR websites.]
So basically in order to control the virus, we need to treat mainly the low- and middle-income countries (LMICs) population where Hepatitis C is more prevalent, however, due to the high cost of current conventional treatments for HCV, it is not financially possible, therefore I recommend using natural remedies which are reasonably affordable and are very effective!
1. Ryan KJ, Ray CG M. Sherris Medical Microbiology (4th ed.) United States of America: McGraw-Hill, 2004 Published. Print.
2. Wilkins, Thad, et al. “Hepatitis C: diagnosis and treatment.” Am Fam Physician81.11 (2010): 1351-1357.
3. de Almeida Pondé, Robério Amorim. “Hidden hazards of HCV transmission.”Medical microbiology and immunology 200.1 (2011): 7-11.
4. Jafari, Siavash, et al. “Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis.”International Journal of Infectious Diseases 14.11 (2010): e928-e940.
5. Lam, NC; Gotsch, PB, Langan, RC (2010-11-15). “caring for pregnant women and newborns with hepatitis B or C”
6. Davison, John W., et al. “Effectiveness of a hepatitis C group education class in Veterans Administration treatment settings.”The 2005 National Viral Hepatitis Prevention Conference. 2005.
7. Gene-Eden-VIR is Antiviral: Results of a Post marketing clinical study. Published in September 2013. scirp.org/journal/PaperInformation.aspx?PaperID=36101#.VE44nyKUf90
8. PharmaTimes.com – Grogan, K. “HCV services in England declared unacceptable.” Published on November 4, 2014